Inducible nitric oxide synthase (iNOS) expression in monocytes during acute Dengue Fever in patients and during in vitro infection

BMC Infectious Diseases

Volumn 5, Issue , 2005, Pages

  Neves Souza, Patrícia C F ^a   Azeredo, Elzinandes L ^a   Zagne, Sonia M O ^b   Valls de Souza, Rogério ^c   Reis, Sonia R N I ^a   Cerqueira, Denise I S ^a   Nogueira, Rita M R ^a   Kubelka, Claire F ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b HOSPITAL UNIVERSITÁRIO ANTÔNIO PEDRO   (Brazil)

^c Funda??o Oswaldo Cruz   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; VIRUS ANTIGEN;

ACUTE DISEASE; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL CLONE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; ENZYME INHIBITION; FLOW CYTOMETRY; FREQUENCY ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; MONOCYTE; MOSQUITO; NONHUMAN; PROTEIN EXPRESSION; VIRUS REPLICATION; ANIMAL; CELL LINE; ENZYMOLOGY; GENE EXPRESSION REGULATION; LYMPHOCYTE; METABOLISM; PATHOLOGY; PHYSIOLOGY; TIME; VIROLOGY;

ACUTE DISEASE; ANIMALS; ANTIGENS, VIRAL; CELL LINE; DENGUE; DENGUE VIRUS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LYMPHOCYTES; MONOCYTES; NITRIC OXIDE SYNTHASE TYPE II; TIME FACTORS;

EID: 27344455580     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-5-64     Document Type: Article

References (51)

1. Halstead SB: Pathogenesis of dengue: challenges to molecular biology. Science 1988, 239(4839):476-481.
2. Monath TP: Pathobiology of the Flaviviruses. In he Togoviridae and Flaviviridae Edited by: Schlesinger SSMJ. New York, Plenun Press; 1986:375-440.
3. Scott RM, Nisalak A, Cheamudon U, Seridhoranakul S, Nimmannitya S: Isolation of dengue viruses from peripheral blood leukocytes of patients with hemorrhagic fever. J Infect Dis 1980, 141(1):1-6.
4. Tassaneetrithep B, Burgess TH, Granelli-Piperno A, Trumpfheller C, Finke J, Sun W, Eller MA. Pattanapanyasat K, Sarasombath S, Birx DL, Steinman RM, Schlesinger S, Marovich MA: DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells. J Exp Med 2003, 197(7):823-829.
5. Wu SJ, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R, Louder MK, Filgueira L, Marovich MA, Wong HK, Blauvelt A, Murphy GS, Robb ML, Innes BL, Birx DL, Hayes CG, Frankel SS: Human skin Langerhans cells are targets of dengue virus Infection. Nat Med 2000, 6(7):816-820.
6. Morens DM, Marchette NJ, Chu MC, Halstead SB: Growth of dengue type 2 virus isolates in human peripheral blood leukocytes correlates with severe and mild dengue disease. Am J Trop Med Hyg 1991, 45(5):644-651.
7. Wang HL, Lin KH, Yueh YY, Chow L, Wu Y, Chen HY, Sheu MM, Chen WJ: Efficient diagnosis of dengue infections using patients' peripheral blood leukocytes and serum/plasma. Intervirology 2000, 43:107-111.
8. Azeredo EL, Reis SRIN, Zagne SMO, Miagostovich M, Nogueira RM, Kubelka CF: Detection of dengue virus in peripheral mononuclear cells from patients using flow cytometry: Mangaratiba, Rio de Janeiro, Brazil. ; 2003.
9. Jessie K, Fong MY, Devi S, Lam SK, Wong KT: Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 2004, 189(8):1411-1418.
10. Rothman AL, Ennis FA: Immunopathogenesis of Dengue hemorrhagic fever. Virology 1999, 257(1):1-6.
11. Guidotti LG, Chisari FV: Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001, 19:65-91.
12. Azeredo EL, Zagne SM, Santiago MA, Gouvea AS, Santana AA, Neves-Souza PC, Nogueira RM, Miagostovich MP, Kubelka CF: Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiology 2001, 204(4):494-507.
13. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, Lew R, Innis BL, Kurane I, Rothman AL, Ennis FA: Early Immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 1999, 179(4):755-762.
14. Kurane I, Innis BL, Nisalak A, Hoke C, Nimmannitya S, Meager A, Ennis FA: Human T cell responses to dengue virus antigens. Proliferative responses and Interferon gamma production. J Clin Invest 1989 83(2):506-513.
15. Kurane I, Ennis FA: Production of interferon alpha by dengue virus-infected human monocytes. J Gen Virol 1988, 69 (Pt 2):445-449.
16. Akaike TMH: Nitric oxide and virus infection. Immunology 2000, 101(3):300-308.
17. Chen RF, Yeh WT, Yang MY, Yang KD: A model of real-time correlation of viral titers with immune reactions in antibody-dependent enhancement of Dengue-2 infections. FEMS Immunol Med Microbiol 2001, 30(1):1-7.
18. Jiang H, Stewart CA, Leu RW: Tumor-derived factor synergizes with IFN-gamma and LPS, IL-2 or TNF-alpha to promote macrophage synthesis of TNF-alpha and TNF receptors for autocrine induction of nitric oxide synthase and enhanced nitric oxide-mediated tumor cytotoxicity. Immunobiology 1995, 192(5):321-342.
19. Valero N, Espina LM, Anez G, Torres E, Mosquera JA: Short report: increased level of serum nitric oxide in patients with dengue. Am J Trop Med Hyg 2002, 66(6):762-764.
20. Marianneau P, Steffan AM, Royer C. Drouet MT, Jaeck D, Kirn A, Deubel V: Infection of primary cultures of human Kupffer cells by Dengue virus: no viral progeny synthesis, but cytokine production is evident J Virol 1999, 73(6):5201-5206.
21. Espina LM, Valero NJ, Hernandez JM, Mosquera JA: Increased apoptosis and expression of tumor necrosis factor-alpha caused by infection of cultured human monocytes with dengue virus. Am J Trop Med Hyg 2003, 68(1):48-53.
22. Reed LJ, Muench H: A simple method of estimating fifty per cent endpoints. Am J Hyg 1938, 27:493-497.
23. Miagostovich MP, Nogueira RM, Cavalcanti SM, Marzochi KB, Schatzmayr HG: Dengue epidemic in the state of Rio de Janeiro, Brazil: virological and epidemiological aspects. Rev Inst Med Trop Sao Paulo 1993, 35(2):149-154.
24. Schoepp RJ, Beaty BJ: Titration of dengue viruses by immunofluorescence in microtiter plates. J Clin Microbial 1984 20(5):1017-1019.
25. Akarid K, Sinet M, Desforges B, Gougerot-Pocidalo MA: Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J Virol 1995, 69(11):7001-7005.
26. Sydow FF, Santiago MA, Neves-Souza PC, Cerqueira DI, Gouvea AS, Lavatori MF, Bertho AL, Kubelka CF: Comparison of dengue infection in human mononuclear leukocytes with mosquito C6/36 and mammalian Vero cells using flow cytometry to detect virus antigen. Mem Inst Oswaldo Cruz 2000, 95(4):483-489.
27. Cologna R, Rico-Hesse R: American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol 2003, 77(7):3929-3938.
28. Benencia F, Courreges MC: Nitric oxide and macrophage antiviral extrinsic activity. Immunology 1999, 98(3):363-370.
29. Chen YC, Wang SY: Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide. J Virol 2002, 76(19):9877-9887.
30. Lin YW, Wang KJ, Lei HY, Lin YS, Yeh TM, Liu HS, Liu CC, Chen SH: Virus replication and cytokine production in dengue virus-infected human B lymphocytes. J Virol 2002, 76(23):12242-12249.
31. Halstead SB, Porterfield JS, O'Rourke EJ: Enhancement of dengue virus infection in monocytes by flavivirus antisera. Am J Trop Med Hyg 1980, 29(4):638-642.
32. Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A: Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A 2003, 100(24):14333-14338.
33. Karupiah G, Xie QW, Buller RM, Nathan C, Duarte C, MacMicking JD: Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science 1993, 261(5127):1445-1448.
34. Yee Lj, Knapp S, Burgner D, Hennig BJ, Frodsham AJ, Wright M, Thomas HC, Hill AV, Thursz MR: Inducible nitric oxide synthase gene (NOS2A) haplotypes and the outcome of hepatitis C virus infection. Genes Immun 2004, 5(3):183-187.
35. Kreil TR, Eibl MM: Nitric oxide and viral infection: NO antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo. Virology 1996, 219(1):304-306.
36. Saura M, Zaragoza C, McMillan A, Quick RA, Rohenadl C, Lowenstein JM, Lowenstein CJ: Antiviral mechanims of nitric oxide: inhibition of viral proteinase. Immunity 1999, 10:21-28.
37. MacLean X, Wei XQ, Huang FP, Al-Alem AH, Chan WL, Liew FY: Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th I responses. J Gen Virol 1998, 79:825-830.
38. Chesler DA, Dodard, C. Lee GY, Levy DE, Reiss CS: Interferon-gamma-induced inhibition of neuronal vesicular stomatitis virus infection is STATI dependent. J Neurovirol 2004, 10(1):57-63.
39. Sharara AI, Perkins DJ, Misukonis MA, Chan SU, Dominitz JA, Weinberg JB: Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo. J Exp Med 1997, 186(9):1495-1502.
40. Lin YL, Huang YL, Ma SH, Yeh CT, Chiou SY, Chen LK, Liao CL: Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J Virol 1997, 71(7);5227-5235.
41. Wolkow PP: Involvement and dual effects of nitric oxide in septic shock. Inflamm Res 1998, 47(4):152-166.
42. Weinberg JB, Misukonis MA, Shami PJ, Mason SN, Sauls DL, Dittman WA, Wood ER, Smith GK, McDonald B, Bachus KE, et al.: Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 1995, 86(3):1184-1195.
43. Denis M: Human monocytes/macrophages: NO or no NO? J Leukoc Biol 1994, 55(5):682-684.
44. Gantt KR, Goldman TL, McCormick ML, Miller MA, Jeronimo SM, Nascimento ET, Britigan BE, Wilson ME: Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J Immunol 2001, 167(2):893-901.
45. Jaramillo M, Naccache PH, Olivier M: Monosodium urate crystals synergize with IFN-gamma to generate macrophage nitric oxide: involvement of extracellular signal-regulated kinase 1/2 and NF-kappa B. J Immunol 2004, 172(9):5734-5742.
46. Plum J, Huang C, Grabensee B, Schror K, Meyer-Kirchrath J: Prostacyclin enhances the expression of LPS/INF-gamma-induced nitric oxide synthase in human monocytes. Nephron 2002, 91(3):391-398.
47. Perez-Mediavilla LA, Lopez-Zabalza MJ, Calonge M, Montuenga L, Lopez-Moratalla N, Santiago E: Inducible nitric oxide synthase in human lymphomononuclear cells activated by synthetic peptides derived from extracellular matrix proteins. FEBS Lett 1995, 357(2):121-124.
48. Imanishi N, Andoh T, Sakai S, Satoh M, Katada Y, Ueda K, Terasawa K, Ochiai H: Induction of Inducible Nitric Oxide (NO) Synthase mRNA and NO Production in Macrophages Infected with Influenza A/PR/8 Virus and Stimulated with Its Ether-Split Product. Microbiol Immunol 2005, 49(1):41-48.
49. Camargo MM, Andrade AC, Almeida IC, Travassos LR, Gazzinelli RT: Glycoconjugates isolated from Trypanosoma cruzi but not from Leishmania species membranes trigger nitric oxide synthesis as well as microbicidal activity in IFN-gamma-primed macrophages. J Immunol 1997, 159(12):6131-6139.
50. Keller CC, Kremsner PG, Hittner JB, Misukonis MA, Weinberg JB, Perkins DJ: Elevated nitric oxide production in children with malarial anemia: hemozoin-induced nitric oxide synthase type 2 transcripts and nitric oxide in blood mononuclear cells. Infect Immun 2004, 72(8):4868-4873.
51. Rimmelzwaan GF, Baars MMJW, Lijster P, Fouchier RAM, Osterhaus ADME: Inhibition of influenza virus replication by nitric oxide. J Virol 1999, 73:8880-8883.